Arkolith/Insider Trading/KROS/Form 4

ADAR1 Capital Management, LLC

10% OwnerKeros Therapeutics, Inc. (KROS) · full profile →Form 4 · filed Jun 12, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 16, 2025Expiration(E)836—$00
May 16, 2025Expiration(E)300—$00
May 16, 2025Expiration(E)178—$00

Transaction Codes

E
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-058955) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML